Novel insights into human respiratory syncytial virus-host factor interactions through integrated proteomics and transcriptomics analysis

Research output: Contribution to journalReview articlepeer-review

17 Citations (Scopus)

Abstract

The lack of vaccine and limited antiviral options against respiratory syncytial virus (RSV) highlights the need for novel therapeutic strategies. One alternative is to develop drugs that target host factors required for viral replication. Several microarray and proteomics studies had been published to identify possible host factors that are affected during RSV replication. In order to obtain a comprehensive understanding of RSV-host interaction, we integrated available proteome and transcriptome datasets and used it to construct a virus-host interaction network. Then, we interrogated the network to identify host factors that are targeted by the virus and we searched for drugs from the DrugBank database that interact with these host factors, which may have potential applications in repositioning for future treatment options of RSV infection.

Original languageEnglish
Pages (from-to)285-297
Number of pages13
JournalExpert Review of Anti-Infective Therapy
Volume14
Issue number3
DOIs
Publication statusPublished - 2016 Mar 3

Keywords

  • Drug-drug target interaction network
  • Microarray analysis
  • Protein-protein interaction network
  • Proteomics
  • Respiratory syncytial virus
  • Virus-host interactions
  • human

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)
  • Virology
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Novel insights into human respiratory syncytial virus-host factor interactions through integrated proteomics and transcriptomics analysis'. Together they form a unique fingerprint.

Cite this